A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Completed · Phase 3

Conditions studied: Myeloid Leukemia, Chronic

In brief

The purpose of this clinical research study is to compare the confirmed complete cytogenetic response of dasatinib with that of imatinib within 12 months after randomization in patients with newly diagnosed chronic-phase Philadelphia positive chronic myeloid leukemia. The safety of this treatment will also be studied.

Key facts

Study ID

NCT00481247

Run by

Bristol-Myers Squibb

People needed

547

Starts

2007-09-01

Expected to finish

2015-12-01

Last updated by the study team

2017-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Local Institution — Buenos Aires, Buenos Aires, Argentina
• Local Institution — Capital Federal, Buenos Aires, Argentina
• Local Institution — Capital Federal, Buenos Aires, Argentina
• Local Institution — Waratah, New South Wales, Australia
• Local Institution — Brisbane, Queensland, Australia
• Local Institution — Greenslopes, Queensland, Australia
• Local Institution — Perth, Western Australia, Australia
• Local Institution — Innsbruck, Austria
• Local Institution — Vienna, Austria
• Local Institution — Bruges, Belgium
• Local Institution — Brussels, Belgium
• Local Institution — Curitiba, Paraná, Brazil
• Local Institution — Rio de Janeiro, Rio de Janeiro, Brazil
• Local Institution — Campinas, São Paulo, Brazil
• Local Institution — Jaú, São Paulo, Brazil
• Local Institution — São Paulo, São Paulo, Brazil
• Local Institution — São Paulo, São Paulo, Brazil
• Local Institution — Santiago, Santiago Metropolitan, Chile
• Local Institution — Beijing, Beijing Municipality, China
• Local Institution — Fuzhou, Fujian, China
• Local Institution — Shanghai, Shanghai Municipality, China
• Local Institution — Tianjin, Tianjin Municipality, China
• Local Institution — Colombia, Bogota D.C., Colombia
• Local Institution — Bogotá, Colombia
• Molecular Md — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.